Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Vlado Perkovic

ResearcherPublications, citations & collaboration network

Vlado Perkovic is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 58 works, 2,466 citations, an h-index of 11 and an i10-index of 12.

58
Works
2,466
Citations
11
h-index
12
i10-index

How has Vlado Perkovic's publication output changed over time?

ScholarIQpublication output · 2024–2026

Output declined80% over the shown period — from 5 works in 2024 to 1 in 2026.

5
5
1
202420252026

What are the most-cited papers on Vlado Perkovic?

ScholarIQmost cited works
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
Vlado Perkovic, Katherine R. Tuttle, Peter Rossing, Kenneth W. Mahaffey, Johannes F.E. Mann, George L. Bakris, Florian M.M. Baeres, Thomas Idorn, Heidrun Bosch‐Traberg, Nanna L. Lausvig, Richard Pratley
New England Journal of Medicine. 20241,655 Citations
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials
Sunil V. Badve, Anika Bilal, Matthew M.Y. Lee, Naveed Sattar, Hertzel C. Gerstein, Christian T. Ruff, John J.V. McMurray, Peter Rossing, George Bakris, Kenneth W. Mahaffey, Johannes F.E. Mann, Helen M. Colhoun, Katherine R Tuttle, Richard E. Pratley, Vlado Perkovic
The Lancet Diabetes & Endocrinology. 2024293 CitationsOPEN ACCESS
Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials
Ellen M. Apperloo, Brendon L. Neuen, Robert A. Fletcher, Niels Jongs, Stefan D. Anker, Deepak L. Bhatt, Javed Butler, David Z.I. Cherney, William G. Herrington, Silvio E. Inzucchi, Meg Jardine, Chih‐Chin Liu, Kenneth W. Mahaffey, Darren K. McGuire, John J.V. McMurray, Bruce Neal, Milton Packer, Vlado Perkovic, Marc S. Sabatine, Scott D. Solomon, Natalie Staplin, Michael Szarek, Muthiah Vaduganathan, Christoph Wanner, David C. Wheeler, Stephen D. Wiviott, Faïez Zannad, Hiddo J.L. Heerspink
The Lancet Diabetes & Endocrinology. 2024141 CitationsOPEN ACCESS
Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial
Richard E. Pratley, Katherine R. Tuttle, Peter Rossing, Søren Rasmussen, Vlado Perkovic, Olav Wendelboe Nielsen, Johannes F.E. Mann, Richard J. MacIsaac, Mikhail Kosiborod, Zdravko Kamenov, Thomas Idorn, Marco Bo Hansen, Samy Hadjadj, George L. Bakris, Florian M.M. Baeres, Kenneth W. Mahaffey
Journal of the American College of Cardiology. 2024114 CitationsOPEN ACCESS
SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria
Brendon L. Neuen, Robert A. Fletcher, Stefan D. Anker, Deepak L. Bhatt, Javed Butler, David Z.I. Cherney, Kieran F. Docherty, Silvio E. Inzucchi, Meg Jardine, Kenneth W. Mahaffey, Finnian R. Mc Causland, Darren K. McGuire, John J.V. McMurray, Bruce Neal, Milton Packer, Siddharth M. Patel, Vlado Perkovic, Marc S. Sabatine, Rebecca J. Sardell, Scott D. Solomon, Muthiah Vaduganathan, C. Wanner, David C. Wheeler, Faïez Zannad, Richard Haynes, Natalie Staplin, William G. Herrington, Hiddo J.L. Heerspink, Brendon L. Neuen, Hiddo JL Heerspink, Stefan D. Anker, Deepak L. Bhatt, Javed Butler, David Z.I. Cherney, Kieran F. Docherty, Adrian F. Hernandez, William G. Herrington, Silvio E. Inzucchi, Stefan James, Meg Jardine, Kenneth W. Mahaffey, Darren K. McGuire, John J.V. McMurray, Bruce Neal, Milton Packer, Siddharth M. Patel, Vlado Perkovic, Marc S. Sabatine, Natalie Staplin, Scott Solomon, Muthiah Vaduganathan, Christoph Wanner, David C. Wheeler, Faiez Zannad
JAMA. 202553 CitationsOPEN ACCESS

Related on ScholarIQ

UNSW Sydney
Institution
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
Paper
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials
Paper
Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials
Paper
Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial
Paper
SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria
Paper
470M+ articles · free account